Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacrofine 0.1% Ointment

Prescription Icon
Prescription Required

Marketer

Geolife Sciences

Salt Composition

Tacrolimus (0.1% w/w)

Overview Tacrofine 0.1% Ointment

Eczema (atopic dermatitis) is treated with Tacrofine 0.1% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Applied externally, this ointment should be gently and evenly rubbed into affected skin 2-4 times daily, or as directed by a physician. Avoid over-application and occlusive dressings. Consult your doctor if symptoms worsen or show no improvement after a fortnight. Common side effects include skin redness, headache, folliculitis, and application site reactions (burning, irritation, itching, redness). Use during pregnancy or breastfeeding is generally discouraged unless medically necessary.

Primary Ingredients of Tacrofine 0.1% Ointment

No text provided to rephrase.

Uses of Tacrofine 0.1% Ointment

Managing atopic dermatitis

Major Benefits of Tacrofine 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines prior to use. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

Common Side effects of Tacrofine 0.1% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacrofine 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Before applying, ensure the affected skin is clean and dry; then, gently rub in the ointment.

How Tacrofine 0.1% Ointment works:

Tacrofine 0.1% Ointment, an immunosuppressant medication, reduces skin inflammation—manifested as redness and swelling—by modulating the activity of specific immune cells. This action alleviates itching and promotes healing in cases of atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacrofine 0.1% Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to any prescription. Consult your physician for guidance.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Application of Tacrofine 0.1% Ointment while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingNone

No drug interaction identified.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacrofine 0.1% Ointment :

Apply Tacrofine 0.1% Ointment as soon as you remember a missed dose. If your next scheduled application is imminent, omit the forgotten dose and resume your usual regimen.

Facts to Know About Tacrofine 0.1% Ointment

LabelValue
Chemical Category Macrolide-Lactam Antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Action Class Calcineurin inhibitor immunosuppressants

FAQs on Tacrofine 0.1% Ointment

Tacrofine 0.1% Ointment is an immunomodulatory medicine, primarily reducing immune system activity. It treats moderate to severe adult eczema (atopic dermatitis) unresponsive to steroids or those experiencing steroid side effects. Atopic dermatitis involves an overactive skin immune system, causing inflammation, itching, redness, and dryness. Tacrofine 0.1% Ointment modifies this abnormal immune response, alleviating inflammation and itching.
Applying Tacrofine 0.1% Ointment may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These side effects usually subside within a week. Use may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacrofine 0.1% Ointment offers a safe and effective short-term treatment for atopic dermatitis, demonstrating superior safety compared to other immunosuppressant medications. Its minimal systemic absorption after topical application results in fewer side effects than oral immunosuppressants.
Tacrolimus 0.1% ointment is not a controlled substance and does not have abuse potential. Controlled substances require authorization from a doctor and relevant authorities due to their potential for misuse.
Prolonged use of Tacrofine 0.1% Ointment may increase the risk of lymphoma (a type of lymph node tumor). Studies show a link between Tacrofine 0.1% Ointment, or similar medications, and the development of skin cancer or lymphoma in a small number of patients. Consult your physician if Tacrofine 0.1% Ointment use exceeds six weeks, or if your eczema symptoms worsen or fail to improve.
Tacrofine 0.1% Ointment is a non-steroidal medication that modifies immune system function. Primarily used for eczema, particularly atopic dermatitis, it avoids the skin thinning and other side effects associated with steroids.
Tacrofine 0.1% Ointment
271
MRP 330
17% off